Related Experiment Video
Updated: Jul 29, 2025

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
Published on: November 3, 2023
Risk factors associated with acute kidney injury in a cohort of hospitalized patients with COVID-19
Kateir Contreras-Villamizar1,2,3, Oscar Barbosa4,5, Ana Cecilia Muñoz4,5
1Nephrology Unit, Kr 7 40 62 Hospital Universitario San Ignacio, 110231, Bogotá, DC, Colombia. kcontreras@husi.org.co.
Insights
Male sex, older age, and pre-existing conditions like chronic kidney disease and high blood pressure increase the risk of acute kidney injury (AKI) in COVID-19 patients. Certain medications and vasopressor support also contribute to AKI development.
Area of Science:
- Nephrology
- Infectious Diseases
- Critical Care Medicine
Background:
- COVID-19 is frequently associated with acute kidney injury (AKI), a condition linked to increased patient mortality.
- Identifying factors contributing to AKI in COVID-19 patients is crucial for improving clinical outcomes.
Purpose of the Study:
- To determine the specific factors associated with the development of AKI in hospitalized COVID-19 patients.
- To estimate the incidence of AKI within 28 days of hospital admission for COVID-19.
Main Methods:
- A retrospective cohort study was conducted in two Colombian university hospitals.
- Included were adult patients hospitalized for over 48 hours with confirmed COVID-19 between March 2020 and March 2021.
Main Results:
- Of 1584 patients, 46.5% developed AKI, with 23.6% classified as KDIGO 3 and 11.1% requiring renal replacement therapy.
- Risk factors for AKI included male sex, older age, history of chronic kidney disease (CKD) and high blood pressure (HBP), elevated qSOFA scores, vancomycin, piperacillin/tazobactam use, and vasopressor support.
- Hospital mortality was significantly higher in patients with AKI (45.5%) compared to those without (11.7%).
Conclusions:
- Male sex, advanced age, pre-existing HBP and CKD, elevated qSOFA scores, and the use of nephrotoxic medications and vasopressors are key risk factors for AKI in COVID-19 patients.
- These findings highlight the importance of monitoring kidney function and managing risk factors in hospitalized COVID-19 patients.
Background:
Patients with COVID-19 have a high incidence of acute kidney injury (AKI), which is associated with mortality. The objective of the study was to determine the factors associated with AKI in patients with COVID-19.
Methodology:
A retrospective cohort was established in two university hospitals in Bogotá, Colombia. Adults hospitalized for more than 48 h from March 6, 2020, to March 31, 2021, with confirmed COVID-19 were included. The main outcome was to determine the factors associated with AKI in patients with COVID-19 and the secondary outcome was estimate the incidence of AKI during the 28 days following hospital admission.
Results:
A total of 1584 patients were included: 60.4% were men, 738 (46.5%) developed AKI, 23.6% were classified as KDIGO 3, and 11.1% had renal replacement therapy. The risk factors for developing AKI during hospitalization were male sex (OR 2.28, 95% CI 1.73-2.99), age (OR 1.02, 95% CI 1.01-1.03), history of chronic kidney disease (CKD) (OR 3.61, 95% CI 2.03-6.42), High Blood Pressure (HBP) (OR 6.51, 95% CI 2.10-20.2), higher qSOFA score to the admission (OR 1.4, 95% CI 1.14-1.71), the use of vancomycin (OR 1.57, 95% CI 1.05-2.37), piperacillin/tazobactam (OR 1.67, 95% CI 1.2-2.31), and vasopressor support (CI 2.39, 95% CI 1.53-3.74). The gross hospital mortality for AKI was 45.5% versus 11.7% without AKI.
Conclusions:
This cohort showed that male sex, age, history of HBP and CKD, presentation with elevated qSOFA, in-hospital use of nephrotoxic drugs and the requirement for vasopressor support were the main risk factors for developing AKI in patients hospitalized for COVID-19.
More Related Videos
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury I: Introduction
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury VI: Nursing Management

